Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)

BACKGROUND: Non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have substantially improved anticoagulation therapy for prevention of stroke and systemic embolism in patients with atrial fibrillation (AF). The available routine care data have demonstrated the safety of different NOACs; howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: De Caterina, Raffaele, Kelly, Peter, Monteiro, Pedro, Deharo, Jean Claude, de Asmundis, Carlo, López-de-Sá, Esteban, Weiss, Thomas W., Waltenberger, Johannes, Steffel, Jan, de Groot, Joris R., Levy, Pierre, Bakhai, Ameet, Zierhut, Wolfgang, Laeis, Petra, Kerschnitzki, Michael, Reimitz, Paul-Egbert, Kirchhof, Paulus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625115/
https://www.ncbi.nlm.nih.gov/pubmed/31299906
http://dx.doi.org/10.1186/s12872-019-1144-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625115/
https://www.ncbi.nlm.nih.gov/pubmed/31299906
http://dx.doi.org/10.1186/s12872-019-1144-x

Ejemplares similares